Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Ultra-processed foods significantly increase a person’s risk of heart attack or stroke
Study participants who ate high amounts of ultra-processed foods were 66.8% more likely to experience a heart attack, stroke or cardiac arrest than those who did not.
Acute kidney injury after TAVR: Key risk factors every cardiologist should know
Multiple studies have linked acute kidney injury after TAVR to a heightened risk of short- and long-term mortality.
Single injection could help heal heart attack damage
Amplifying the body’s natural release of a specific hormone may reduce stress on the heart and limit long‑term damage after myocardial infarctions.
FDA approves JenaValve TAVR system for aortic regurgitation
The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.
ACIP meeting postponed after judge pauses RFK’s new vaccine recommendations
Judge Brian Murphy with the U.S. District Court of Massachusetts sided with the American Academy of Pediatrics and other plaintiffs who challenged the authority of HHS Secretary Robert F. Kennedy Jr to effectively remove the Advisory Committee on Immunization Practices from the process put in place to make changes to CDC vaccine recommendations.

Ultra-processed foods significantly increase a person’s risk of heart attack or stroke

Study participants who ate high amounts of ultra-processed foods were 66.8% more likely to experience a heart attack, stroke or cardiac arrest than those who did not.

Acute kidney injury after TAVR: Key risk factors every cardiologist should know

Multiple studies have linked acute kidney injury after TAVR to a heightened risk of short- and long-term mortality.

A single injection of saNppa lipid nanoparticles enables self-amplification and high-yield pro-ANP production for more than 28 days. Circulating pro-ANP is selectively cleaved by the cardiac protease corin into active ANP, activating NPR1/cGMP signaling in the heart. Image courtesy of Science, Kaiyue Zhang et al. https://www.science.org/doi/10.1126/science.adu9394

Single injection could help heal heart attack damage

Amplifying the body’s natural release of a specific hormone may reduce stress on the heart and limit long‑term damage after myocardial infarctions.

FDA approves JenaValve TAVR system for aortic regurgitation

The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.

ACIP meeting postponed after judge pauses RFK’s new vaccine recommendations

Judge Brian Murphy with the U.S. District Court of Massachusetts sided with the American Academy of Pediatrics and other plaintiffs who challenged the authority of HHS Secretary Robert F. Kennedy Jr to effectively remove the Advisory Committee on Immunization Practices from the process put in place to make changes to CDC vaccine recommendations.

Afnan Tariq, MD, JD, FSCAI, FACC, an interventional cardiologist, assistant clinical professor of medicine at University of California, Irvine, presented first-in-man data on a passive, device-agnostic artificial intelligence (AI) platform for heart failure monitoring using consumer wearables at the recent Technology and Heart Failure Therapeutics (THT) 2026 meeting. The study showed the AI could help lower repeat hospitalizations.

AI turns wearable device data into actionable insights for heart failure patients

Afnan Tariq, MD, discusses early data on a passive, device-agnostic AI platform for heart failure monitoring. “When clinicians are empowered with insights and able to act earlier, you're able to have a durable impact," he said.

Amir Lerman, MD, a veteran cardiologist with Mayo Clinic, died unexpectedly on Feb. 23. He was 69 years old.

Pioneer cardiologist Amir Lerman remembered as a ‘true giant’ of the specialty

Lerman, who spent nearly 40 years with Mayo Clinic, was especially influential in the treatment of nonobstructive CAD.

Researchers develop program that can spot falsified radiology reports written by AI

“With generative AI becoming more capable of producing remarkably convincing radiology reports, there’s a greater risk of fabricated reports being used to falsify medical histories and support fraudulent claims,” the team cautioned.